Tag Archives: NASDAQ:MBOT

Analysts Offer Insights on Healthcare Companies: Microbot Medical (NASDAQ: MBOT), Revance Therapeutics (NASDAQ: RVNC) and KemPharm (NASDAQ: KMPH)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Microbot Medical (MBOT – Research Report), Revance Therapeutics (RVNC – Research Report) and KemPharm (KMPH – Research Report) with bullish sentiments. Microbot

Microbot Medical Inc (MBOT) Receives a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Microbot Medical Inc (MBOT – Research Report), with a price target of $10. The company’s shares closed last Monday at $6.40. Selvaraju commented: “Our price

H.C. Wainwright Sticks to Their Buy Rating for Microbot Medical Inc (MBOT)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Microbot Medical Inc (MBOT – Research Report) today and set a price target of $10. The company’s shares closed last Monday at $5.42. Selvaraju observed: “Our price target is derived